Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 132 participants.
Also called NCT01346215
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 132 participants
- Sponsor
- Laboratório Químico Farmacêutico Bergamo Ltda.
- Registry
-
NCT01346215
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Unknown status
Technical summary
Registry record NCT01346215. Randomized; single masking; primary purpose prevention. Start 2011-10 (registry gives no type); primary completion 2011-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure
- Condition
- Chronic Renal Failure
- Intervention (Biological)
- heparin sodium
- Intervention (Biological)
- heparin sodium
- Lead sponsor
- Laboratório Químico Farmacêutico Bergamo Ltda.
- Collaborator
- Azidus Brasil
Record details
- Record id
cardio:ct-nct01346215- Content hash
f74dbe581e33382c63bcbc872089b71f87db4ca642cbfb303fbed7b2b7b10aa3